Weight-Loss Drugs Reshape Super Bowl Snacks

Super Bowl Sunday's classic spread of high-calorie foods is evolving as more Americans embrace GLP-1 appetite-suppressing medications. These drugs are significantly altering dietary habits, leading individuals like Florida retiree Marla Senzon to opt for lighter meals such as salads and lean proteins instead of traditional game-day fare. This shift represents a move away from previous diet fads, with industry leaders viewing the GLP-1 trend as a more enduring change.

Food companies are responding by adapting their strategies, with an emphasis on smaller portion sizes, increased fiber, and higher protein content. PepsiCo's CEO indicated a sense of urgency in capitalizing on this trend, while Good Times Restaurants is introducing protein bowls to its core menu. This adaptation also addresses rising business costs, as many restaurant operators are adjusting portion sizes due to increased expenses, with altered appetites from drug users being a contributing factor.

The burgeoning market for weight-loss drugs is also influencing product development towards healthier options. Demand is growing for high-protein, lower-sugar foods, such as Greek yogurt, and meal-kit companies are offering GLP-1-friendly recipes. The increasing accessibility and falling prices of these medications suggest a continued shift in consumer spending towards foods that align with health-conscious choices, including protein shakes and nutrient-dense snacks.